A Study of Cell Therapy in COVID-19 Subjects With Acute Kidney Injury Who Are Receiving Renal Replacement Therapy

NCT04445220 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19
Acute Kidney Injury
Sepsis

Interventions

BIOLOGICAL: SBI-101

Sponsor

Sentien Biotechnologies, Inc.